Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability

被引:0
|
作者
Xingbao Li
Raffaella Ricci
Charles H. Large
Berry Anderson
Ziad Nahas
Mark S. George
机构
[1] Medical University of South Carolina,Brain Stimulation Laboratory, Department of Psychiatry
[2] GlaxoSmithKline S.p.A.,Medicines Research Centre
来源
Journal of Neural Transmission | 2009年 / 116卷
关键词
Lamotrigine; Valproic acid; Transcranial magnetic stimulation; Motorcortical excitability;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate different cortical effects of lamotrigine and valproic acid, 30 paid healthy adult men were given, in a randomized/blinded fashion on three separate days (separated by a week), either a single dose of lamotrigine 325 mg, or a single dose of valproic acid 1,250 mg, or placebo. Resting motor threshold (RMT), cortical silent period (CSP) and motor evoked potential recruitment curves (RC) were assessed at baseline and 3 h after administration of each medication (or placebo). Lamotrigine caused a significant increase (63.32 vs. 69.25) in the RMT, compared with an insignificant increase following valproic acid (62.50 vs. 63.35), and a decrease (62.60 vs. 62.36) following placebo (F2,26 = 18.58, P < 0.0001). No significant difference in CSP was found between placebo and drugs (F2,26 = 0.119, P > 0.05). RCs were significantly suppressed by lamotrigine (t = 2.07, P < 0.05) and enhanced by valproic acid (t = 2.39, P < 0.05). Lamotrigine and valproic acid have different effects on cortical neuronal excitability as demonstrated by TMS.
引用
收藏
页码:423 / 429
页数:6
相关论文
共 50 条
  • [22] Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid
    Viteri, C.
    Codina, M.
    Cobaleda, S.
    Lahuerta, J.
    Barriga, J.
    Morales, M. D.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2010, 19 (07): : 432 - 438
  • [24] Clinical study of lamotrigine and valproic acid in patients with epilepsy: Using a drug interaction to advantage?
    Morris, RG
    Black, AB
    Lam, E
    Westley, IS
    THERAPEUTIC DRUG MONITORING, 2000, 22 (06) : 656 - 660
  • [25] Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy
    Hwang, Hee
    Kim, Hunmin
    Kim, Seung Hyo
    Kim, Se Hee
    Lim, Byung Chan
    Chae, Jong-Hee
    Choi, Ji Eun
    Kim, Ki Joong
    Hwang, Yong Seung
    BRAIN & DEVELOPMENT, 2012, 34 (05) : 344 - 348
  • [26] Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling
    Xu, Shansen
    Liu, Limin
    Chen, Yanan
    Liu, Mei
    Lu, Tong
    Wang, Huanxin
    Liu, Shihao
    Zhao, Mingming
    Zhao, Limei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (05) : 583 - 591
  • [27] Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling
    Shansen Xu
    Limin Liu
    Yanan Chen
    Mei Liu
    Tong Lu
    Huanxin Wang
    Shihao Liu
    Mingming Zhao
    Limei Zhao
    European Journal of Clinical Pharmacology, 2018, 74 : 583 - 591
  • [28] Lamotrigine versus valproic acid monotherapy for generalised epilepsy: A meta-analysis of comparative studies
    Tang, Linjun
    Ge, Linbo
    Wu, Weijun
    Yang, Xuguang
    Rui, Pinhe
    Wu, Yong
    Yu, Wan
    Wang, Xi
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 51 : 95 - 101
  • [29] Does Valproic Acid Have potential in the Treatment of Diabetes Mellitus?
    Rakitin, Aleksei
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8